Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609674 · ClinicalTrials.gov registry record · Phase 4
A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 315
- Enrollment target
NCT00609674 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 315 participants.
The verdict
NCT00609674, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 315 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects (effectiveness and safety) of an intranasal corticosteroid (fluticasone furoate nasal spray \[FFNS\]), with a placebo nasal spray for the treatment of perennial (year-round) allergic rhinitis.
Interventions
- DRUG Placebo
- DRUG Fluticasone furoate nasal spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00609674
The ClinicalTrials.gov registry entry for NCT00609674 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00609674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00609674 about?
NCT00609674 is a clinical study titled "A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis". The purpose of this study is to compare the effects (effectiveness and safety) of an intranasal corticosteroid (fluticasone furoate nasal spray \[FFNS\]), with a placebo nasal spray for the treatment of perennial (year-round) allergic rhinitis.
What is the current status of trial NCT00609674?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 315 participants. The study started on 2008-01. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00609674?
The interventions under investigation include: Placebo (DRUG), Fluticasone furoate nasal spray (DRUG).
Who is sponsoring clinical trial NCT00609674?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.